KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells

Acute myeloid leukemia (AML) is a clonal hematologic malignant disease of developing myeloid cells that have acquired aberrant survival, uncontrolled proliferation and a block in normal hematopoietic cell differentiation. Standard chemotherapy often induces remissions in AML patients, but the diseas...

詳細記述

保存先:
書誌詳細
出版年:Leukemia
主要な著者: Etchin, J, Berezovskaya, A, Conway, A S, Galinsky, I A, Stone, R M, Baloglu, E, Senapedis, W, Landesman, Y, Kauffman, M, Shacham, S, Wang, J C Y, Look, A T
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2017
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5220128/
https://ncbi.nlm.nih.gov/pubmed/27211268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2016.145
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料